| Literature DB >> 35239742 |
Abstract
Q fever is a zoonosis caused by Coxiella burnetii. In Germany, the common sources of human infections include small ruminants that excrete the pathogen. Q fever in humans can be asymptomatic or nonspecific. However, severe disease progression is also possible, which can lead to death. Q fever in small ruminants is usually asymptomatic, although reproductive disorders may occur. To protect humans from Q fever, it is important that human and veterinary health professionals (practitioners/health authority employees) have comprehensive knowledge of the diagnosis, control and prevention of Q fever, and its zoonotic potential. To ensure and enhance this understanding, this stakeholder analysis assessed Q fever expertise in human and veterinary health professionals in Germany and investigated how these knowledge gaps can best be resolved. For this purpose, an online survey and two focus group discussions were conducted with 836 and 18 participants, respectively. Knowledge gaps are due to a lack of awareness of Q fever, especially among human health practitioners. Moreover, colleagues who have heard about Q fever still lack the necessary cross-species knowledge to successfully diagnose, control and prevent this zoonosis. Additionally, differences exist between stakeholders regarding their work context and the region in which they work. In this study, stakeholders in southwestern Germany had slightly better Q fever knowledge than their colleagues in northeastern Germany. In addition, information sources aimed at resolving knowledge gaps involve direct conversations between the stakeholders, as well as reading materials and seminars. Each of these information sources should focus on interdisciplinary resources to strengthen the cooperation between human and veterinary health professionals and to raise awareness of the strengths of each stakeholder group. These results have already been implemented by the Q-GAPS project, with goals of raising awareness of Q fever and filling knowledge gaps.Entities:
Mesh:
Year: 2022 PMID: 35239742 PMCID: PMC8893703 DOI: 10.1371/journal.pone.0264629
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Methodology of this stakeholder analysis.
Fig 2Plausibility check and data sets (online survey).
Description of human and veterinary health professionals of Germany based on the field of specialization (online survey).
| Stakeholder group | Field of specialization the stakeholder work in | Study population | |
|---|---|---|---|
| n | % | ||
|
| |||
| Practitioners | Gynecology and obstetrics medicine | 61 | 38.61 |
| General medicine | 39 | 24.68 | |
| Internal medicine | 26 | 16.46 | |
| Other | 22 | 13.92 | |
| Not specified | 5 | 3.16 | |
| Laboratory | 4 | 2.53 | |
| Infection protection, hygiene and environmental medicine | 1 | 0.63 | |
| Total | 158 | 100.00 | |
| Health authority employees | Infection protection, hygiene and environmental medicine | 46 | 24.86 |
| Public health | 43 | 23.24 | |
| Other | 30 | 16.22 | |
| Internal medicine | 25 | 13.51 | |
| Not specified | 21 | 11.35 | |
| General medicine | 16 | 8.65 | |
| Laboratory | 3 | 1.62 | |
| Gynecology and obstetrics medicine | 1 | 0.54 | |
| Total | 185 | 100.00 | |
|
| |||
| Practitioners | Farm animals, in general | 73 | 54.48 |
| Farm animals, especially cattle | 38 | 28.36 | |
| Farm animals, especially small ruminants | 19 | 14.18 | |
| Laboratory work | 4 | 2.99 | |
| Total | 134 | 100.00 | |
| Health authority employees | Farm animals, in general | 288 | 80.22 |
| Laboratory work | 48 | 13.37 | |
| Farm animals, especially small ruminants | 17 | 4.74 | |
| Farm animals, especially cattle | 6 | 1.67 | |
| Total | 359 | 100.00 | |
n = study population size; Other = other field of specialization than the ones listed here.
Description of human and veterinary health practitioners of Germany based on the region they work in (online survey).
| Stakeholder group | Region the stakeholder work in | Target population | Study population | ||
|---|---|---|---|---|---|
| N | % | n | % | ||
|
| |||||
| Practitioners | Northeastern Germany | 119,898 | 33.39 | 100 | 63.29 |
| Southwestern Germany | 239,201 | 66.61 | 55 | 34.81 | |
| Not specified | - | - | 3 | 1.90 | |
| Total | 359,099 | 100.00 | 158 | 100.00 | |
| Health authority employees | Northeastern Germany | 4,133 | 41.25 | 54 | 29.19 |
| Southwestern Germany | 5,887 | 58.75 | 128 | 69.19 | |
| Not specified | - | - | 3 | 1.62 | |
| Total | 10,020 | 100.00 | 185 | 100.00 | |
|
| |||||
| Practitioners | Northeastern Germany | 7,786 | 36.70 | 69 | 51.49 |
| Southwestern Germany | 13,431 | 63.30 | 57 | 42.54 | |
| Not specified | - | - | 8 | 5.97 | |
| Total | 21,217 | 100.00 | 134 | 100.00 | |
| Health authority employees | Northeastern Germany | 2,822 | 43.31 | 140 | 39.00 |
| Southwestern Germany | 3,694 | 56.69 | 212 | 59.05 | |
| Not specified | - | - | 7 | 1.95 | |
| Total | 6,516 | 100.00 | 359 | 100.00 | |
1 Berlin, Brandenburg, Bremen, Hamburg, Mecklenburg-West Pomerania, Lower Saxony, Saxony, Saxony-Anhalt, Schleswig-Holstein;
2 Baden-Wurttemberg, Bavaria, Hesse, North Rhine-Westphalia, Rhineland-Palatinate, Saarland, Thuringia.
N = target population size; n = study population size
Multivariable logistic regression analysis of the proportion of correct answers of human health professionals (online survey).
| Question | Variable | Category | Proportion of correct answers/correct and wrong answers (%) | Odds ratio (OR) | 95% confidence interval (Cl) | Chi Square p-value | Likelihood-Ratio p-value |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Awareness of term Qfever* | Stkh group | HHP | 111/143 (77.62) | 6.95 | 2.54–19.01 |
|
|
| HHAE | 169/174 (97.13) | ||||||
| Region | NE | 118/147 (80.27) | 2.78 | 1.17–6.60 |
| ||
| SW | 162/170 (95.29) | ||||||
| Based on case report: Consideration of Q fever as DD if the participant is aware of term Q fever* | Stkh group | HHP | 9/111 (8.11) | 1.17 | 0.49–2.82 | 0.7225 | 0.0700 |
| HHAE | 21/169 (12.43) | ||||||
| Region | NE | 7/118 (5.93) | 2.48 | 0.97–6.31 | 0.0575 | ||
| SW | 23/162 (14.20) | ||||||
|
| |||||||
| Human health: Risk estimation for developing acute Q fever if the following events occur | |||||||
| Visit of markets with animal exhibition* | Stkh group | HHP | 54/96 (56.25) | 0.96 | 0.55–1.69 | 0.8975 | 0.3667 |
| HHAE | 87/148 (58.78) | ||||||
| Region | NE | 53/101 (52.48) | 1.47 | 0.84–2.56 | 0.1740 | ||
| SW | 88/143 (61.54) | ||||||
| Hiking in areas with sheep farming* | Stkh group | HHP | 46/92 (50.00) | 2.11 | 1.20–3.74 |
|
|
| HHAE | 103/147 (70.07) | ||||||
| Region | NE | 53/97 (54.64) | 1.37 | 0.78–2.42 | 0.2762 | ||
| SW | 96/142 (67.61) | ||||||
|
| |||||||
| Human health: Evaluation of the following statements of acute Q fever | |||||||
| An illness of acute Q fever during pregnancy can lead to an abortion | Stkh group | HHP | 72/80 (90.00) | 2.28 | 0.737.15 | 0.1580 | 0.2407 |
| HAE | 133/139 (95.68) | ||||||
| Region | NE | 77/84 (91.67) | 1.32 | 0.42–4.10 | 0.6340 | ||
| SW | 128/135 (94.81) | ||||||
| Outbreaks of acute Q fever in the human population are often associated with diseases of pigeons (wild, city or private pigeon populations) | Stkh group | HHP | 55/75 (73.33) | 2.08 | 0.98–4.40 | 0.0551 | 0.0933 |
| HHAE | 119/139 (85.61) | ||||||
| Region | NE | 67/86 (77.91) | 1.11 | 0.53–2.36 | 0.7786 | ||
| SW | 107/128 (83.59) | ||||||
| Diagnostic laboratory tests in connection with acute Q fever must be billed privately to the patient | Stkh group | HHP | 89/92 (96.74) | 1.68 | 0.24–11.80 | 0.6034 | 0.5554 |
| HHAE | 128/130 (98.46) | ||||||
| Region | NE | 84/87 (96.55) | 1.95 | 0.29–13.74 | 0.5007 | ||
| SW | 133/135 (98.52) | ||||||
| Illnesses of acute Q fever should be treated with antibiotics | Stkh group | HHP | 74/86 (86.05) | 5.07 | 1.77–14.50 |
|
|
| HHAE | 136/143(95.10) | ||||||
| Region | NE | 88/93 (94.62) | 0.26 | 0.08–0.83 |
| ||
| SW | 122/136 (89.71) | ||||||
| According to the IfSG, the clinically diagnosed Q fever should be reported to the responsible health authority before the laboratory result is obtained | Stkh group | HHP | 42/80 (52.50) | 2.75 | 1.46–5.15 |
|
|
| HHAE | 97/133 (72.93) | ||||||
| Region | NE | 54/83 (65.06) | 0.71 | 0.38–1.35 | 0.2985 | ||
| SW | 85/130 (65.38) | ||||||
| According to the IfSG, the responsible health authority will then forward the case of Q fever, which has thus far only been clinically diagnosed, to the competent state authority | Stkh group | HHP | 32/67 (47.76) | 2.87 | 1.49–5.53 |
|
|
| HHAE | 101/133 (75.94) | ||||||
| Region | NE | 41/76 (53.95) | 1.78 | 0.93–3.41 | 0.0815 | ||
| SW | 92/124 (74.19) | ||||||
| Your patient is protected against secondary diseases of acute Q fever by the antibodies detected in the laboratory | Stkh group | HHP | 56/79 (70.89) | 0.95 | 0.48–1.88 | 0.8912 | 0.4626 |
| HHAE | 89/122 (72.95) | ||||||
| Region | NE | 51/76 (67.11) | 1.51 | 0.77–2.97 | 0.2292 | ||
| SW | 94/125 (75.20) | ||||||
| Acute Q fever can become chronic in some cases and may lead to endocarditis, vasculitis, osteomyelitis, hepatitis, pneumonia or neurological manifestation | Stkh group | HHP | 82/84 (97.62) | 0.42 | 0.08–2.25 | 0.3140 | 0.5396 |
| HHAE | 123/130 (94.62) | ||||||
| Region | NE | 79/82 (96.34) | 1.03 | 0.23–4.56 | 0.9658 | ||
| SW | 126/132 (95.45) | ||||||
Significant variables (p < 0.05, likelihood ratio test) are printed in bold.
*Correct answer = Yes, Very high risk/High risk and Agree completely/Rather agree, respectively; wrong answer = No, Low risk/Very low risk and Disagree rather/ Disagree completely, respectively;
**Correct answer = Disagree rather/Disagree completely; wrong answer = Agree completely/Rather agree, respectively;
Stkh group = Stakeholder group;
HHP = Human health practitioners; HHAE = Human health authority employees;
NE = Northeastern Germany (Berlin, Brandenburg, Bremen, Hamburg, Mecklenburg-West Pomerania, Lower Saxony, Saxony, Saxony-Anhalt, Schleswig-Holstein);
SW = Southwestern Germany (Baden-Wurttemberg, Bavaria, Hesse, North Rhine-Westphalia, Rhineland-Palatinate, Saarland, Thuringia);
DD = Differential diagnosis; IfSG = German Protection against Infection Act.
Multivariable logistic regression analysis of the proportion of correct answers of veterinary health professionals (online survey).
| Question | Variable | Category | Proportion of correct answers/correct and wrong answers (%) | Odds ratio (OR) | 95% confidence interval (Cl) | Chi Square p-value | Likelihood-Ratio p-value |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Awareness of term (acute) Q fever | Stkh group | VHP | 119/120 (99.17) | 0.93 | 0.09–9.19 | 0.9481 | 0.9701 |
| VHAE | 344/347 (99.14) | ||||||
| Region | NE | 204/206 (99.03) | 1.28 | 0.18–9.35 | 0.8068 | ||
| SW | 259/261 (99.23) | ||||||
| Based on case report: Consideration of Q fever as DD | Stkh group | VHP | 64/119 (53.78) | 1.46 | 0.95–2.24 | 0.0826 |
|
| VHAE | 222/344 (64.53) | ||||||
| Region | NE | 113/204 (55.39) | 1.55 | 1.06–2.27 |
| ||
| SW | 173/259 (66.80) | ||||||
|
| |||||||
| Small ruminants flock health: Risk estimation for developing Q fever if the following events occur | |||||||
| Exhibition of individual animals of the herd (e.g., breeding shows, animal auctions) | Stkh group | VHP | 74/99 (74.75) | 0.85 | 0.50–1.44 | 0.5444 | 0.0842 |
| VHAE | 205/293 (69.97) | ||||||
| Region | NE | 129/168 (76.79) | 0.63 | 0.40–0.99 | 0,045 | ||
| SW | 150/224 (66.96) | ||||||
| Grazing on land that was grazed by sheep and goats more than one year ago | Stkh group | VHP | 42/90 (46.67) | 1.29 | 0.79–2.08 | 0,308 | 0.1927 |
| VHAE | 151/279 (54.12) | ||||||
| Region | NE | 75/157 (47.78) | 1.33 | 0.88–2.02 | 0,183 | ||
| SW | 118/212 (55.66) | ||||||
| Multiple lambing in the same bay, without cleaning and disinfection in between | Stkh group | VHP | 95/101 (94.06) | 1.27 | 0.46–3.54 | 0,646 | 0.1090 |
| VHAE | 288/300 (96.00) | ||||||
| Region | NE | 161/173 (93.06) | 2.66 | 0.97–7.33 | 0,059 | ||
| SW | 222/228 (97.37) | ||||||
|
| |||||||
| Small ruminants flock health: Evaluation of the following statements of Q fever | |||||||
| Q fever can proceed subclinical in sheep, despite excretion of the pathogen | Stkh group | VHP | 93/95 (97.89) | 1.03 | 0.192–5.46 | 0,977 | 0.3273 |
| VHAE | 284/289 (98.27) | ||||||
| Region | NE | 163/168 (97.02) | 3.27 | 0.62–17.30 | 0,163 | ||
| SW | 214/216 (99.07) | ||||||
| Q fever diseases lead to persistent immunity of the animals after infestation of a herd of small ruminants | Stkh group | VHP | 50/82 (60.98) | 1.17 | 0.69–1.96 | 0,564 | 0.3943 |
| VHAE | 171/261 (65.51) | ||||||
| Region | NE | 88/145 (60.69) | 1.30 | 0.83–2.04 | 0,253 | ||
| SW | 133/198 (67.17) | ||||||
| Outbreaks of Q fever in the human population are often associated with events where sheep shearing is demonstrated | Stkh group | VHP | 59/83 (71.08) | 1.76 | 1.0–3.11 | 0,052 | 0.0524 |
| VHAE | 227/277 (100.00) | ||||||
| Region | NE | 119/157 (75.80) | 1.39 | 0.83–2.34 | 0,215 | ||
| SW | 167/203 (82.27) | ||||||
| Leading symptoms of Q fever in the human population are exanthema, roseoles, papules, blisters and crusts | Stkh group | VHP | 75/81 (92.59) | 0.55 | 0.22–1.35 | 0,191 | 0.3830 |
| VHAE | 234/268 (87.31) | ||||||
| Region | NE | 129/146(88.36) | 1,09 | 0.56–2.12 | 0,811 | ||
| SW | 180/203 (88.67) | ||||||
| According to TierGesG, the indirect pathogen detection should be reported to the responsible veterinary office | Stkh group | VHP | 34/76 (44.74) | 0.99 | 0.58–1.68 | 0,971 | 0.9603 |
| VHAE | 100/226 (44.25) | ||||||
| Region | NE | 58/126 (46.03) | 0.94 | 0.59–1.49 | 0,783 | ||
| SW | 76/174 (43.68) | ||||||
| Since | Stkh group | VHP | 83/87 (95.40) | 0.90 | 0.28–2.84 | 0,852 | 0.9215 |
| VHAE | 253/267 (94.76) | ||||||
| Region | NE | 145/152 (95.39) | 0.85 | 0.32–2.27 | 0,747 | ||
| SW | 191/202 (94.55) | ||||||
| To prevent Q fever losses at the next lambing, the flock should be vaccinated at least 3 weeks prior to covering | Stkh group | VHP | 66/75 (88.00) | 0.69 | 0.32–1.52 | 0,356 | 0.6235 |
| VHAE | 190/227 (83.70) | ||||||
| Region | NE | 107/127 (84.25) | 1.11 | 0.59–2.10 | 0,749 | ||
| SW | 149/175 (85.14) | ||||||
| Raw milk products can still be marketed after Coxiella burnetii is directly detectable in 1 of 45 vaginal swab samples | Stkh group | VHP | 87/89 (97.75) | 0.41 | 0.09–1.85 | 0,244 | 0.4371 |
| VHAE | 252/266 (94.73) | ||||||
| Region | NE | 148/155 (95.48) | 1.10 | 0.40–3.05 | 0,855 | ||
| SW | 191/200 (95.50) | ||||||
Significant variables (p < 0.05, likelihood ratio test) are printed in bold.
*Correct answer = Yes, Very high risk/High risk and Agree completely/Rather agree, respectively; wrong answer = No, Low risk/Very low risk and Disagree rather/Disagree completely, respectively;
**Correct answer = Disagree rather/Disagree completely; wrong answer = Agree completely/Rather agree, respectively;
Stkh group = Stakeholder group;
VHP = Veterinary health practitioners; VHAE = Veterinary health authority employees;
NE = Northeastern Germany (Berlin, Brandenburg, Bremen, Hamburg, Mecklenburg-West Pomerania, Lower Saxony, Saxony, Saxony-Anhalt, Schleswig-Holstein);
SW = Southwestern Germany (Baden-Wurttemberg, Bavaria, Hesse, North Rhine-Westphalia, Rhineland-Palatinate, Saarland, Thuringia);
DD = Differential diagnosis; TierGesG = German National Animal Health Act.
Most suitable information sources to close knowledge gaps about Q fever (focus group discussions).
| Stakeholder group | Sub categories | |
|---|---|---|
| Detail Level 1 | Detail Level 2 | |
| HHP | Direct conversation | • Conversation partners |
| Reading material | • Open Access | |
| Seminars | • Academic education | |
| HHAE | Direct conversation | • Conversation partners |
| Reading material | • Legislation | |
| Seminars | • Conferences | |
| VHP | Direct conversation | • Conversation partners |
| Reading material | • Official guidance documents | |
| Seminars | • Advanced education | |
| VHAE | Direct conversation | • Conversation partners |
| Reading material | • Open Access | |
| Seminars | • Advanced education | |
HHP = Human health practitioners; HHAE = Human health authority employees;
VHP = Veterinary health practitioners; VHAE = Veterinary health authority employees.